Tactics and technologies to manage nonadherence in patients with schizophrenia

William M. Glazer, Mathew J. Byerly

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The occurrence of treatment nonadherence among patients with schizophrenia is clinically significant. However, studies show that clinicians do not make systematic efforts to identify and monitor it over time. This paper reviews the various tactics for identifying and monitoring adherence behavior. A comprehensive review of published studies comparing typical and atypical antipsychotics in terms of medication adherence yields mixed results at best. Changing forces in the delivery of health care in the United States will promote efforts to improve the recognition of nonadherence in patients with schizophrenia and develop strategies and tactics to decrease the current rates of nonadherence. Such tactics are described in this paper, and emerging best practices are identified. Ultimately, if nonadherence rates are to decrease, it will be necessary to align the incentives of the treater and the treated.

Original languageEnglish (US)
Pages (from-to)359-369
Number of pages11
JournalCurrent Psychiatry Reports
Volume10
Issue number4
DOIs
StatePublished - Aug 2008

Fingerprint

Patient Compliance
Schizophrenia
Technology
Medication Adherence
Practice Guidelines
Antipsychotic Agents
Motivation
Delivery of Health Care

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Tactics and technologies to manage nonadherence in patients with schizophrenia. / Glazer, William M.; Byerly, Mathew J.

In: Current Psychiatry Reports, Vol. 10, No. 4, 08.2008, p. 359-369.

Research output: Contribution to journalArticle

Glazer, William M. ; Byerly, Mathew J. / Tactics and technologies to manage nonadherence in patients with schizophrenia. In: Current Psychiatry Reports. 2008 ; Vol. 10, No. 4. pp. 359-369.
@article{2b5d720b40f14a44b38f112fcb8acde3,
title = "Tactics and technologies to manage nonadherence in patients with schizophrenia",
abstract = "The occurrence of treatment nonadherence among patients with schizophrenia is clinically significant. However, studies show that clinicians do not make systematic efforts to identify and monitor it over time. This paper reviews the various tactics for identifying and monitoring adherence behavior. A comprehensive review of published studies comparing typical and atypical antipsychotics in terms of medication adherence yields mixed results at best. Changing forces in the delivery of health care in the United States will promote efforts to improve the recognition of nonadherence in patients with schizophrenia and develop strategies and tactics to decrease the current rates of nonadherence. Such tactics are described in this paper, and emerging best practices are identified. Ultimately, if nonadherence rates are to decrease, it will be necessary to align the incentives of the treater and the treated.",
author = "Glazer, {William M.} and Byerly, {Mathew J.}",
year = "2008",
month = "8",
doi = "10.1007/s11920-008-0057-7",
language = "English (US)",
volume = "10",
pages = "359--369",
journal = "Current Psychiatry Reports",
issn = "1523-3812",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Tactics and technologies to manage nonadherence in patients with schizophrenia

AU - Glazer, William M.

AU - Byerly, Mathew J.

PY - 2008/8

Y1 - 2008/8

N2 - The occurrence of treatment nonadherence among patients with schizophrenia is clinically significant. However, studies show that clinicians do not make systematic efforts to identify and monitor it over time. This paper reviews the various tactics for identifying and monitoring adherence behavior. A comprehensive review of published studies comparing typical and atypical antipsychotics in terms of medication adherence yields mixed results at best. Changing forces in the delivery of health care in the United States will promote efforts to improve the recognition of nonadherence in patients with schizophrenia and develop strategies and tactics to decrease the current rates of nonadherence. Such tactics are described in this paper, and emerging best practices are identified. Ultimately, if nonadherence rates are to decrease, it will be necessary to align the incentives of the treater and the treated.

AB - The occurrence of treatment nonadherence among patients with schizophrenia is clinically significant. However, studies show that clinicians do not make systematic efforts to identify and monitor it over time. This paper reviews the various tactics for identifying and monitoring adherence behavior. A comprehensive review of published studies comparing typical and atypical antipsychotics in terms of medication adherence yields mixed results at best. Changing forces in the delivery of health care in the United States will promote efforts to improve the recognition of nonadherence in patients with schizophrenia and develop strategies and tactics to decrease the current rates of nonadherence. Such tactics are described in this paper, and emerging best practices are identified. Ultimately, if nonadherence rates are to decrease, it will be necessary to align the incentives of the treater and the treated.

UR - http://www.scopus.com/inward/record.url?scp=48749088556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48749088556&partnerID=8YFLogxK

U2 - 10.1007/s11920-008-0057-7

DO - 10.1007/s11920-008-0057-7

M3 - Article

VL - 10

SP - 359

EP - 369

JO - Current Psychiatry Reports

JF - Current Psychiatry Reports

SN - 1523-3812

IS - 4

ER -